“DOVER, Del. (AP) — Chemical and bioscience company DuPont Co. says weakness in its performance chemicals and electronics and communications businesses, coupled with costs associated with growth initiatives, led to a sharp drop in fourth-quarter income.
The company on Tuesday reported net income for the quarter ending Dec. 31 of $111 million, or 12 cents per share, excluding significant items, compared to net income of $373 million, or 40 cents per share, for the fourth quarter of 2011.
But the results beat the consensus estimate of Wall Street analysts of 7 cents per share. Its shares rose 91 cents, or 1.9 percent, to $47.90 in premarket trading.
DuPont chairwoman and CEO Ellen Kullman said the company is stronger than it was a year ago, having posted a record year in new product introductions.
“However, weakness in markets served by performance chemicals and electronics and communications provided significant challenges in 2012,” she said. “We’ve adjusted our plans to meet the changing market environment and grow our businesses in a slow-growth world economy.”
Sales for the quarter were flat at $7.3 billion, with currency effects and portfolio changes offsetting a 3 percent increase in global volumes. Sales in Latin America grew 10 percent, with an 8 percent volume gain and a 7 percent increase in local prices. A 6 percent increase in volume in the Asia-Pacific region, was offset by negative currency and pricing effects.
Analysts expected revenue of $7.2 billion.
One-time items affecting fourth-quarter results included $135 million to resolve legal claims stemming from the use of DuPont’s Imprelis weedkiller, bringing the total amount spent on Imprelis claims to $750 million.
DuPont, based in Wilmington, Del., also recorded asset impairment and restructuring charges totaling $99 million, and a pretax gain of $117 million associated with the sale of a business within its agricultural unit….”
If you enjoy the content at iBankCoin, please follow us on Twitter
